Keynote OCT Nordics

Unlocking Objective, Continuous and Unbiased Data - Adoption of Wearable Sensors in Clinical Trials

Clinical trials are evolving – no longer limited to questionnaires and clinic visits. In this keynote, we’ll explore how wearable sensors and digital endpoints are transforming trial design, enabling objective, real-world measurement while reducing participant burden.

Don’t miss this chance to see how the future of clinical research is being rewritten – join us in Copenhagen!

Keynote Spotlight

Session: “Unlocking Objective, Continuous and Unbiased Data – Adoption of Wearable Sensors in Clinical Trials”

This session explores the transformative role of wearable sensors in modern clinical trials, highlighting their potential to enhance data quality and patient experience.

Key topics include:

  • The rationale for sensor integration: How wearable technologies can reduce patient burden while delivering continuous, objective, and unbiased data.
  • Real-world insights: Lessons learned from a large-scale study involving 450 participants using wearable sensors.
  • Innovation spotlight: An exclusive introduction to a new, next-generation sensor platform.
  • Future outlook: A preview of emerging advancements and how they are reshaping the future of clinical research.
 

Join this session to discover how wearable sensors are driving greater efficiency, reliability, and patient-centricity in clinical trials.

Can’t Join Us in Copenhagen?

No problem – you can still be part of the conversation.

Sign up to get on-demand access to the keynote “Unlocking Objective, Continuous and Unbiased Data – Adoption of Wearable Sensors in Clinical Trials” and explore how wearable technology, sensors, and gamified data collection are redefining evidence in modern clinical research.

Watch it whenever it suits you – and see how digital endpoints are bringing trials closer to patients, and insights closer to reality.

Visit us at Booth 44
OCT Nordics 2025

Let’s shape the future of dermatology together.

Where to find Replior this October